Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Cardiol Therapeutics Inc. (CRDL) had Debt to Equity Ratio of 0.01 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-8.29M |
|
-- |
|
-- |
|
$8.43M |
|
$-8.43M |
|
$0.14M |
|
$-8.29M |
|
$-8.29M |
|
$-8.29M |
|
$-8.29M |
|
$-8.29M |
|
$-8.29M |
|
$-8.43M |
|
$-8.41M |
|
82.61M |
|
82.61M |
|
$-0.10 |
|
$-0.10 |
|
| Balance Sheet Financials | |
$17.60M |
|
$0.13M |
|
$0.13M |
|
$17.73M |
|
$5.40M |
|
$0.08M |
|
$0.08M |
|
$5.48M |
|
$12.25M |
|
$12.25M |
|
$12.25M |
|
82.61M |
|
| Cash Flow Statement Financials | |
$-4.98M |
|
$-0.01M |
|
$-0.01M |
|
$21.30M |
|
$16.22M |
|
$-5.07M |
|
$0.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.26 |
|
-- |
|
-- |
|
0.01 |
|
|
Debt to Equity Ratio |
0.01 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.99M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-67.66% |
|
-67.66% |
|
-46.75% |
|
-67.22% |
|
$0.15 |
|
$-0.06 |
|
$-0.06 |
|